Intravoxel incoherent motion (IVIM) is an MR-based diffusion-weighted imaging technique that can measure both diffusion and perfusion. Currently, no link has been established between the perfusion parameters obtained from IVIM to those from dynamic contrast-enhanced (DCE)-MRI, particularly in the human brain. This study determined that no correlation exists between these two perfusion measurement techniques in patients with glioblastomas. This indicates that these two imaging techniques measure two separate effects; however, IVIM may be able to provide complementary, additional perfusion information that can potentially aid clinical diagnoses when used in conjunction with DCE-MRI parameters.
Several methods are used to measure perfusion effects with MRI. In this work, two of these methods will be considered: intravoxel incoherent motion (IVIM) and dynamic contrast-enhanced (DCE)-MRI. It stands to reason that, since they both measure perfusion, a close relationship should exist between the two sets of perfusion parameters. Conversely, if this is not the case, then they characterize different, possibly complimentary, tissue parameters. Currently, there is no reported link between perfusion parameters obtained from IVIM and DCE-MRI. The purpose of this work was to investigate the relationship between these two MR perfusion acquisitions in glioblastomas.
DCE-MRI is a well-established technique for detecting contrast agents as they pass through tissues by relating associated signal changes to tissue perfusion characteristics1. IVIM is a non-contrast diffusion-weighted imaging (DWI) technique that differentiates signal contributions due to diffusion from those due to perfusion2. On a macroscopic scale, blood flow through the microvasculature can be considered incoherent due to the pseudorandom structure of the vessels2; this process is called pseudo-diffusion and manifests as an additional component to the diffusion decay. To observe the IVIM effect, sequentially stronger diffusion gradients differentiate stationary molecules from those undergoing diffusion3. This is modelled by
$$S(b)=S_0[f\cdot e^{-bD^*}+(1-f)\cdot e^{-bD}] \ \ \ (1)$$
where S(b) is the signal-intensity for a given b-value, S0 is the signal-intensity at b=0, f is the perfusion fraction, D is the diffusion coefficient, and D* is the pseudo-diffusion coefficient. Several different methods to evaluate IVIM parameters using Eq. 1 are reported in the literature2,4,5.
The authors would like to thank Christian Federau for his guidance in establishing our IVIM protocol and data processing methods.
1. Padhani AR and Husband JE. Dynamic Contrast-enhanced MRI Studies in Oncology with an Emphasis on Quantification, Validation and Human Studies. Clin Radiol. 2001;56(8):607-620.
2. Le Bihan D, Breton E, Lallemand D, et al. Separation of Diffusion and Perfusion in Intravoxel Incoherent Motion MR Imaging. Radiology. 1988;168(2):497-505.
3. Sigmund EE and Jensen J. (2011). Basic physical principles of body diffusion-weighted MRI. In B. Taouli (Ed.), Extra-Cranial Applications of Diffusion-Weighted MRI (pp. 1-17). New York, NY: Cambridge University Press.
4. Keil VC, Mädler B, Gielen GH, et al. Intravoxel Incoherent Motion MRI in the Brain: Impact of the Fitting Model on Perfusion Fraction and Lesion Differentiability. J Magn Reson Imaging. 2017;46(4):1187-1199.
5. Bisdas S, Braun C, Skardelly M, et al. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? NMR Biomed. 2014;27(10):1184-1191.
6. Lee EY, Hui ES, Chan KK, et al. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers. J Magn Reson Imaging. 2015;42(2):454-459.